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Abstract
Objective: We describe the frequency and attributes of tuberculosis testing and treatment at four publicly-funded HIV
clinics.
Methods: We abstracted medical records from a random sample of 600 HIV-infected patients having at least one clinic visit
in 2009 at four clinics in New York and Los Angeles Metropolitan Statistical areas. We described testing and treatment for
tuberculosis infection (TBI), 2008–2010, and estimated adjusted odds ratios (aORs). We interviewed key informants and
described clinic policies and practices.
Results: Of 600 patients, 500 were eligible for testing, and 393 (79%) were tested 2008–2010; 107 (21%) did not receive at
least one tuberculin skin test or interferon gamma release assay. Results were positive in 20 (5%) patients, negative in 357
(91%), and unknown in 16 (4%). Fourteen (70%) of 20 patients with TBI initiated treatment at the clinics; only three were
documented to have completed treatment. Three hundred twenty three (54%) patients had chest radiography, 346 (58%)
had tuberculosis symptom screening, and three had tuberculosis disease (117 per 100,000 person-years, 95% confidence
interval (CI) = 101–165). Adjusting for site, non-Hispanic ethnicity (aOR = 4.9, 95% CI = 2.6–9.5), and employment (aOR = 1.9,
95% CI = 1.0–3.4) were associated with TBI testing; female gender (aOR = 2.0, 95% CI = 1.4–3.3), non-black race (aOR = 1.7,
95% CI = 1.3–2.5), and unemployment (aOR = 1.5, 95% CI = 1.1–2.1) were associated with chest radiography. Clinics
evaluated TBI testing performance annually and identified challenges to TB prevention.
Conclusions: Study clinics routinely tested patients for TBI, but did not always document treatment. In a population with a
high TB rate, ensuring treatment of TBI may enhance TB prevention.
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Introduction
Persons living with HIV (PLWH) have a 20 to 37-fold increased
risk of active tuberculosis (TB) disease compared with persons who
are not infected with HIV[1]. Even in settings with low TB
incidence, low HIV prevalence, and access to highly active
antiretroviral therapy (HAART), PLWH are at high risk for TB,
with an estimated incidence of 215 per 100,000 in the first three
months of HAART [2]. Independent risk factors for TB after
HAART initiation in the United States (U.S.) and Canada include
baseline CD4 lymphocyte count less than 200, non-white race,
Hispanic ethnicity, and history of injection drug use [2]. To
prevent TB among PLWH, U.S. guidelines recommend prompt
identification and treatment of TB infection (TBI). TBI testing
with the tuberculin skin test (TST) or an interferon gamma release
assay (IGRA) on whole blood is recommended at entry into HIV
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care and annually for those at substantial risk of exposure to
Mycobacterium tuberculosis [3]. A positive result should trigger rapid
evaluation for active TB disease, including screening for TB
symptoms and chest radiography [3]. HIV-infected individuals
who test positive for TBI without evidence of TB disease should
receive treatment for TBI [3]. Additionally, any patient with newly
diagnosed HIV should be evaluated for TB disease with
assessment of patient history and chest radiography [4].
Past studies have shown that these guidelines are not followed
among a substantial number of PLWH; only one-half to two-thirds
of patients in care for HIV underwent TBI testing and only two-
thirds of newly identified TBI patients received treatment [5–7].
We hypothesized that TB services for PLWH had improved since
these publications, so we sought to determine the frequency and
attributes of TB detection and prevention activities at four
publicly-funded HIV clinics in 2008–2010, at a time when TB
disease and TB-HIV co-infection had declined [8].
Methods
Ethics Statement
The U.S. Centers for Disease Control and Prevention
Institutional Review Board B and the California Health and
Human Services Agency’s Committee for the Protection of
Human Subjects (CPHS) and the Los Angeles County Public
Health Institutional Review Board and each of four clinics
Institutional Review Boards (IRBs) approved the study and
granted a waiver of patient informed consent and patient
authorization for the clinic record reviews. (All three criteria for
such a waiver were satisfied: 1) the use or disclosure of protected
health information (PHI) involves no more than a minimal risk to
the privacy of individuals, 2) the research could not practicably be
conducted without the waiver, and 3) the research could not be
conducted without access to and use of the PHI.) All institutional
review boards that approved the study also approved the following
approach. All participating clinic staff interviewed gave written
informed consent. However, to eliminate the possibility of
identification of the interviewee through linkage of consent form
signatures, a waiver of documentation of informed consent under
45 CFR 46.117(c) enabled the use of a check box rather than a
signature to indicate consent was obtained; the interviewer then
signed the consent form.
Study population
Two U.S. Metropolitan Statistical Areas (MSA) with elevated
HIV and TB prevalence were selected: New York City and Los
Angeles. The Ryan White HIV/AIDS Program (RWP) of the
Health Resources and Services Administration (HRSA) addresses
the health needs of low-income PLWH by funding primary HIV
care (http://hab.hrsa.gov). Two RWP Part C-funded HIV clinics
from each MSA having at least 450 patients annually participated.
All four clinics served predominantly racial/ethnic minority
populations: two were hospital-based, one was a private commu-
nity clinic, and one was a health department clinic. All clinics
participated in the HRSA quality assurance program [9].
Data collection and analysis
Study staff abstracted medical records of a random sample of
600 HIV-infected patients having at least one clinic visit in 2009
(150 consecutive patients from each clinic). We examined patient
characteristics and TB services outcomes (i.e., frequency having
TBI tests, TBI treatment, TB symptom screening, chest radiog-
raphy, and TB disease) during 2008–2010. We concluded data
collection on December 31, 2010. We assumed that chest
radiographs were used for TB evaluation. We used multivariable
logistic regression, with a backwards selection strategy, to identify
patient characteristics that were independently associated with
TBI testing and chest radiography. Variables assessed in the TBI
testing and chest radiography models included those associated
with characteristics in Table 1. We applied a threshold p-value of
0.05 to keep the variable in the model.
We weighted each observation of patient-level data by the
probability of selection at the clinic (inverse of the total clinic
population divided by 150). We estimated the annual rates of TBI
testing, and chest radiography by dividing the total number of tests
by the number of person-years at the clinic. To estimate the TB
disease rate, we first calculated the weighted rate per year; then
selected the median rate and estimated the non-parametric 95%
confidence interval. SAS version 9.2 (SAS Institute Inc., Cary,
North Carolina) was used for statistical analyses.
We collected and abstracted written clinic policies, relevant to
TBI and TB testing, diagnosis, and treatment; and, observed clinic
environment and encounters with patients. Clinic directors (N = 4)
and TB program directors (N = 3) identified their staff who had
sufficient program knowledge to be key informants for the study.
Trained study staff conducted face-to-face key informant inter-
views using a semi-structured instrument, and verified responses
by audio recordings. We reviewed and used data from written
policies, clinic observations, and key informant interviews with
clinic and TB program staff to describe practices of TBI testing,
TBI treatment, TB disease evaluation, and linkages with TB
programs.
Results
Patient characteristics, TB services outcomes, and TB
disease rate
We present characteristics of the 600 patients in Table 1. Two-
thirds of study patients had been in care for HIV at their clinic for
at least five years. The majority of patients were male (N = 419,
70%), and of black race (N = 281, 47%) or Hispanic ethnicity
(N = 246, 41%). Of those with known birth country (N = 415), 157
(38%) were foreign-born, with 97 (62%) born in Mexico. Many
patients had risk factors for TB, including history of: non-injection
drug use (N = 149, 25%), excess alcohol consumption (N = 63,
11%), injection drug use (N = 57, 10%), incarceration (N = 71,
12%), and homelessness (N = 58, 10%). Only two patients had
documented contact with a person with infectious TB. In addition
to HIV infection, patients had other risk factors for TB disease: 68
(11%) had diabetes; 21 (4%) had cancer, 18 (3%) were on
prolonged corticosteroid therapy, five (1%) had hematologic
disease, and five (1%) had end-stage renal disease.
The majority (N = 317, 53%) of patients had a nadir CD4 count
of less than 200. While nearly all (N = 573, 96%) had been on
HAART at some time during the study period, 22% were known
to have started HAART more than once while at the clinic.
Patients without history of TBI or TB were eligible for annual TB
testing, per study clinic policy (see below). Thus, 500 patients
(83%) were eligible for TBI tests in 2008–2010 because they did
not have a history of TBI or TB prior to 2008 (Table 1). One
hundred patients (17%) had TBI (N = 79) or TB disease (N = 21)
prior to 2008.
As shown in Table 2, 393 (79%) of 500 eligible patients were
tested with either a TST or IGRA at least once during 2008–2010.
Of 393 tested, 20 (5%) patients had positive, 357 (91%) had
negative, 14 (4%) had no documented TST results, and two had
indeterminate IGRA results. Of the 20 newly diagnosed TST/
IGRA-positive patients, 13 (65%) had documented TB symptom
TB Prevention Activities at Four Ryan White Program-Funded HIV Clinics
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Table 1. Patient population characteristics.
Characteristic N (%)
Clinic site
Los Angeles MSA 300 (50)





















American Indian/Alaskan Native 5 (1)
Asian 4 (1)





Not U.S.-born 157 (26)
Unknown 185 (31)
Country of birth a
Mexico 97 (62)
El Salvador 13 (8)
Dominican Republic 7 (4)
Guatemala 6 (4)
Cuba 5 (3)
Other Central/South American nation 19 (12)
African nation 6 (4)
Asian nation 3 (2)
Middle Eastern nation 1 (1)
Language
English native 246 (41)
Spanish native 191 (32)
Other language native 5 (1)
Unknown 158 (26)
Social/behavioral/economic
Injection drug use within past year
Yes 57 (10)
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10 or more 184 (31)
Unknown 1 (,1)
Years HIV positive b, median (range) 8.6 (1–28)




500 or over 52 (9)
Unknown 5 (1)




500 or over 196 (33)
Unknown 122 (20)











TB Prevention Activities at Four Ryan White Program-Funded HIV Clinics
PLOS ONE | www.plosone.org 4 July 2014 | Volume 9 | Issue 7 | e101313
screening, and 19 (95%) had documented chest radiography
during 2008–2010. Of the 20 patients who tested positive for TBI,
14 (70%) initiated TBI treatment at the clinic (see Figure 1). Three
(15%) patients were still on treatment when staff concluded data
collection. Excluding the three patients who were still on
treatment, only three (27%) of 11 completed treatment (i.e.,
medical record documented 9 months of INH); two (18%) did not
complete; and six (55%) had no documentation of treatment
completion. One patient who did not complete treatment was
diagnosed with and treated for TB disease (Figure 1).
Of the 357 TST/IGRA-negative patients, 199 (56%) had
documented TB symptom screening, and 160 (45%) had
documented chest radiography (Table 2). One TST-negative
patient was fully evaluated and diagnosed with TB disease. Of the
107 patients not tested for TBI, 62 (58%) had documented TB













5 and more 14 (2)
Unknown 51 (9)
Co-morbidities
Diabetes mellitus 68 (11)
Cancer 21 (4)
Prolonged corticosteroids 18 (3)
Hematologic disease 5 (1)
End-stage renal disease 5 (1)
Contact to infectious TB case 2 (,1)
Had TBI/TB prior to 2008
Yes prior TBI 79 (13)
Yes prior TB disease 21 (4)
No 500 (83)
aOf those born outside U.S.
bBefore December 31, 2010.
cWithin 6 months before or after TST/QFT.
doi:10.1371/journal.pone.0101313.t001
Table 2. Frequency and percent of patients who received TB services, 2008–2010.
Patient history of TBI or TB disease prior to 2008 TST/IGRA N (%) TB symptom-screening N (%) Chest radiography N (%)
500 patients with no prior TBI/TBa 393 (79) 285 (57) 247 (49)
393 were tested with TST/IGRA 223 (57) 190 (48)
357 had negative TST/IGRA 199 (56) 160 (45)
20 had newly positive TST/IGRA 13 (65) 19 (95)
16 had unknown TST/IGRA result 11 (69) 11 (69)
107 were not tested with TST/IGRA 62 (58) 57 (53)
100 patients with prior TBI/TBa 17 (17) 61 (61) 76 (76)
79 with prior TBI 10 (13) 44 (56) 67 (85)
21 with prior TB 7 (33) 17 (81) 9 (43)
aPrior TBI/TB = documented with TBI or TB disease earlier than January 1, 2008.
doi:10.1371/journal.pone.0101313.t002
TB Prevention Activities at Four Ryan White Program-Funded HIV Clinics
PLOS ONE | www.plosone.org 5 July 2014 | Volume 9 | Issue 7 | e101313
Of the 79 patients who had TBI prior to 2008, 44 (56%) had
documented TB symptom screening and 67 (85%) had docu-
mented chest radiography in 2008–2010. One patient in this
group had completed treatment for TBI in 2000, but was
diagnosed with TB disease in 2008, after chest radiography and
specimen collection. Of the 21 patients with TB disease prior to
2008, 17 (81%) had documented TB symptom screening and 9
(43%) had documented chest radiography in 2008–2010 (Table 2).
Overall, among all 600 patients, 323 (54%) had documentation
of chest radiography, and 346 (58%) had documentation of TB
symptom screening at least once during 2008–2010. The median
individual weighted rate of chest radiography was 0.7 times per
year. For the 500 patients eligible for TBI testing, the median
individual weighted rate of TST or IGRA testing was 0.7 times per
year.
Three patients had TB disease during 2008–2010; the median
weighted population rate of TB disease was 117 per 100,000
person years, with a 95% confidence interval of 101–165.
Patient characteristics associated with TBI testing and
chest radiography
Patient characteristics independently associated with TBI testing
included: non-Hispanic ethnicity (adjusted odds ratio (aOR) = 4.9,
95% confidence interval (CI) = 2.6–9.5), receipt of care at a
participating clinic in Los Angeles (aOR = 3.1, 95% CI = 1.5–6.4),
and employment (aOR = 1.9, 95% CI = 1.0–3.4). Patient charac-
teristics associated with having received a chest radiograph
included: female gender (aOR = 2.0, 95% CI = 1.4–3.3); non-
black race (aOR = 1.7, 95% CI = 1.3–2.5); and unemployment
(aOR = 1.5, 95% CI = 1.1–2.1) (Table 3). Country of birth could
not be assessed in the models due to a high frequency (31%) of
missing data.
Programmatic context of TB services
Key informants were interviewed in Los Angeles (n = 12, with 1
from the local TB program) and the New York MSA (n = 8, with 2
from local TB programs). Key informants from each of the four
clinics reported that identification and prevention of TB was a
high priority activity. However, written clinic policies did not
specifically mention TBI testing and treatment, except for Clinic 4
which instructed staff to record annual dates and results of the tests
(Table 4). Clinic 2 outlined the roles and responsibilities of clinic
staff working with the local TB control program to provide directly
observed therapy for patients with TB disease (Table 4). Refer-
ences for clinic policies were reported to be: local or state TB
program manuals, national guidance on HIV primary care [10],
and national guidelines [3,11,12].
Informants from all clinics reported that TST placement and
reading, or IGRA testing, and chest radiography, were provided
during patients’ initial evaluations, i.e., within three months of
intake, and annually thereafter. Clinics 1 and 2 reported the use of
TSTs only, whereas Clinics 3 and 4 used IGRAs in a small
proportion of patients and TSTs in most patients. Clinics 1 and 2
planned to implement IGRAs in the coming year. Informants
confirmed that patients with prior TBI or TB disease were to
receive an annual chest radiograph to assess potentially active TB
disease. All clinics referred patients with positive TSTs/IGRAs for
chest radiography and physician evaluation to rule out TB disease
prior to initiating TBI treatment. Although all clinics had similar
methods to encourage return visits for TST reading, i.e., reminder
phone calls and monitoring of return visits, and reviewed TBI test
completion monthly or quarterly, only Clinics 1 and 4 partnered
with their local TB program to perform systematic monitoring of
TBI testing and treatment (Table 4).
Clinic patients with abnormal chest radiographs were referred
to a clinic-associated hospital or to the local TB clinic for further
assessment and TB treatment, if indicated (Table 4). Each clinic
provided continuity of care for patients on anti-TB treatment. To
support patients undergoing TB services, clinics provided medical
interpreters for non-English-speaking patients, and three clinics
displayed or provided TB-specific patient education materials
(Table 4).
Although all clinics had access to consultation from their local
health department TB program, the extent of the partnership with
the TB program varied. Clinics 1 and 4 had the highest TBI test
rates and reported the most frequent and routine interactions,
including joint monitoring and assessment of TBI testing and
treatment (Table 4). Clinic 1 partnered with its local TB program
to perform systematic review of completion and outcomes of TBI
testing and treatment and Clinic 4 shared and routinely reviewed
patient data with its local TB program. Key informants from two
of the three TB programs that interfaced with the clinics reported
the recent loss of staff that performed partnership activities, e.g.,
monitoring of TBI testing and treatment of patients at HIV clinics.
(Table 4).
Perceived barriers and facilitators of TBI testing and
treatment
In response to an interview question regarding barriers to TBI
testing and treatment, key informants from three clinics reported
that the follow-up visit required for reading the TST was a barrier
for patient retention and completion of TBI testing. According to
clinic staff, IGRAs, while desirable, were of limited utility because
of their high cost and high frequency of indeterminate results. One
Figure 1. Frequency and percent of TBI patients receiving and
completing TBI treatment.
doi:10.1371/journal.pone.0101313.g001
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key informant stated that barriers for completion of TBI treatment
included the perception of a large pill burden, long (9-month)
treatment regimen, and, for immigrant patients, language
differences and uncertain legal status resulting in reluctance to
present for care.
In response to an interview question regarding facilitators to TB
testing and treatment, key informants noted the following: TB
expertise among staff, having sufficient clinic supplies, use of
IGRAs, positive relationships with local TB program staff and
review of shared electronic medical records, use of electronic
patient records and tracking systems to facilitate annual TBI
testing, having staff trained in cultural competency, and the
institutional recognition of the importance of TBI testing. Key
informants from all clinics reported that TBI testing was an
indicator in their HRSA quality management programs.
Discussion
TBI testing was provided to a greater proportion of PLWH in
our study (79%) than in previous studies, (52–65%) [5–7]. Possible
reasons for improved TBI testing in our study compared to
previous studies include underlying differences in the study
populations (e.g. our study population included mostly long-term
clients of four RWP Part C-funded clinics, whereas one of the
previous studies included only patients with newly diagnosed HIV
infection), increased awareness of TB screening recommendations
through time (previous studies examined patients-in-care as early
as 1995 and as recent as 2008), and/or greater performance at our
study clinics which participated in HRSA’s quality improvement
program. Completion of an effective treatment regimen for TBI is
a critical component of TB prevention and study clinics did not
routinely document treatment outcomes.
While this study had small numbers, the occurrence of three TB
cases in 600 patients suggests a high TB rate, which is consistent
with published estimates of the TB rate in HIV-infected persons in
California [8], and emphasizes the importance of screening for TB
disease. Only two clinics documented TB symptom screening in
patient medical records, limiting our ability to assess the extent of
prompt TB detection activities. On the other hand, each clinic
reported policies of annual chest radiographs for its patients;
however, only 54% of patients had received a chest radiograph
during a three year period.
Although Hispanic and black persons are at higher risk of TB
than white persons [8,13], Hispanic patients at the study clinics
were less likely to have TBI testing, and black patients were less
likely to receive chest radiography than other racial/ethnic groups,
even after adjusting for other variables such as employment. We
were unable to adjust for all potential confounding variables, such
as insurance status and other factors associated with health services
utilization so racial/ethnic disparities could not be further
investigated.
Even though each clinic’s goal was to provide annual TBI
testing for all patients, one-fifth of the population did not receive at
least one TST or IGRA during a three-year period. Each clinic
used a variety of approaches to ensure annual TBI testing,
including staff training, quality improvement programs, annual
retrospective review of patient medical records, and real-time
telephone contact to remind patients of and/or reschedule TST
reading visits. Key informants from three clinics stated that a
barrier to annual testing was the challenge of the return visit for
TST reading, even though only 4% of patients had undocumented
TST results. Although replacement of TSTs with IGRAs may
overcome this barrier, many key informants were concerned about
IGRA test performance in HIV-infected populations, and had a
perception that IGRAs produced an unacceptably high frequency
of indeterminate results. However, study patient data revealed that
only 1% of patients tested with IGRAs had an indeterminate
result. The two clinics that were performing only TSTs during the
study period planned to implement IGRAs. IGRAs have greater
specificity (i.e., fewer false-positives) than TST [14], and may
identify fewer patients requiring TBI treatment. However, a subset
of PLWH will have false-negative TST or IGRA test results, which
will require monitoring for TB disease or TBI treatment [15].
One-third of the patients with TBI during 2008–2010 did not
initiate TBI treatment at the clinic. If these patients were not
treated elsewhere, the clinics missed an opportunity to prevent TB.
If lack of documentation was equivalent to lack of treatment, then
the majority of patients with TBI who initiated treatment in this
study did not complete treatment for TBI, and therefore remained
at high risk for progression to TB disease. Since antiretroviral
therapy is associated with decreased incidence of TB [16], patients
who were non-adherent to HAART (approximately one-fifth of
patients started HAART multiple times) would be an important
group for TB prevention. Another risk for progression from TBI to
TB disease is diabetes mellitus (DM) [17], which affected a
substantial percentage (11%) of the study patients. In fact, one of
the study patients with TBI had DM and did not complete
treatment and represents a crucial missed prevention opportunity.
PLWH who also have DM are a group who would benefit from
intensified TB prevention activities.
An important study finding was the absence of TBI treatment
documentation. Each clinic used a HRSA quality assurance
indicator to monitor testing for TBI but employed few, if any,
performance evaluation methods to monitor TBI treatment.
Additional indicators, such as the proportion of patients with
TBI who started and completed treatment, should be implement-
ed to improve documentation of treatment outcomes and TB
Table 3. Patient-level factors associated with TBI testing, and chest radiography.
Factors associated with TBI testing Weighted adjusted OR (95% CI)
Non-Hispanic ethnicity 4.9 (2.6–9.5)
Received care at participating clinic in Los Angeles (ref = New York) 3.1 (1.5–6.4)
Employment 1.9 (1.0–3.4)
Factors associated with chest radiography
Female gender 2.0 (1.4–3.3)
Non-black race 1.7 (1.3–2.5)
Unemployment 1.5 (1.1–2.1)
doi:10.1371/journal.pone.0101313.t003
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prevention. Two of the study clinics had, in the past, worked with
local health department TB program staff to measure progress
towards treatment initiation and completion goals. The two clinics
that performed assessment of TBI testing and treatment outcomes
in partnership with their local TB programs were those that had
the highest TBI testing rate. Perhaps private clinic-based TB
prevention activities would improve with systematic review of
testing and treatment performance indicators, which could be
done in partnership with public health TB programs. A shortened
TBI treatment regimen [18], if shown to be effective and safe in
PLWH, may also improve treatment adherence and completion.
Conclusions
In conclusion, the RWP HIV clinics in our study routinely
tested patients for TBI, but did not always document treatment. In
a population with a high TB rate, ensuring treatment of TBI may
enhance TB prevention.
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No; Described county health-
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treatment procedures
No No Yes; Described clinic-specific
procedures to record annual TST/






No; Described county health-
department wide TBI and TB
patient management and
treatment procedures
Yes; Described clinic-specific staff
roles and responsibilities to
coordinate the administration of
directly observed therapy for TB
patients with the local TB
control program





Radiography in hospital across
the street Patients with
presumptive TB were referred
to local TB clinic
Radiography in clinic Patients
with presumptive TB were
referred to local TB clinic. Clinic
staff worked with local TB
program staff to ensure directly
observed therapy.
Radiography in building that
houses clinic Followed facility
infection control procedures for
patients with presumptive TB
and escorted to emergency
department.
Radiography in building that houses
clinic Patients with presumptive TB
were referred to emergency




nurses completed, and TB
program nurses reviewed,
individual patient tracking
forms to identify gaps in
testing and treatment.
Patient-specific assessment Staff
called patients to remind them
of follow-up visits.
Patient-specific assessment Staff
called patients to remind them
of follow-up visits.
Clinic-wide assessment Clinic staff
directly communicated with TB
program staff, and recorded patient






consultation on TB and
complex TBI cases at clinic.
TB program nurses worked
with clinic nurses
to ensure complete data
collection and follow-up for
patients with TBI (no longer
funded).
Clinic staff worked with TB
program staff to ensure directly
observed therapy of clients
with active TB disease
TB program provided
consultation and TB program
staff member was assigned to
follow up on facility patients
receiving inpatient TB care or
TBI treatment.
TB program provided care and
follow-up of complex clinic patients
with TBI. Shared institutional
affiliation and shared electronic
patient records facilitated exchange
of information and consults.
Infectious Diseases Specialist
provided TB and HIV care at TB
program co-located clinic and
referred to HIV clinic for additional





Clinic nurses provided TB
testing brochures to patients.
Clinic staff ensured continued
HIV care of patients during
at-home recovery from TB
through phone calls and home
visits. TB/HIV patient education
brochures, in Spanish, were
displayed.
Clinic staff utilized treatment
adherence program, providing
tools to patients (e.g., pill boxes),
and counseling on treatment
adherence.
TB and TB/HIV patient education
brochures, in English and Spanish,
were displayed.
aMedian of individual annual weighted rate.
bDocumented in patient medical records.
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